Adoptive transfer of T cells expressing CD19/CD22 bivalent CAR eradicated CD19+/CD22− B-ALL xenografts and significantly inhibited the outgrowth of CD19−/CD22+ B-ALL populations. This evidence concerns the gene CD22 and acute lymphoblastic leukemia.